NewsVandana Singh
Agilent Technologies
A · NYSE
$173.01+$3.11 (+1.83%)TodayMarket closed ·
Prev close $169.90
News sentiment
Tone of recent coverage
Social media sentiment, last 30 days
Average tone of posts mentioning A, from −1 (all negative) to +1 (all positive). Latest day: −0.51 across 27 mentions.
Latest news
- Press releaseBusiness Wire
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
- Press releaseBusiness Wire
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
- Press releaseBusiness Wire
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
- Press releaseBusiness Wire
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
- Press releaseBusiness Wire
Agilent Announces Cash Dividend of 25.5 Cents per Share
- Press releaseBusiness Wire
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
- Press releaseBusiness Wire
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
- Press releaseBusiness Wire
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
- Press releaseBusiness Wire
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
- Press releaseBusiness Wire
Agilent Introduces the Cary 635 FTIR Spectrometer
- News
Agilent Technologies Q3 2026 Earnings Call: Complete Transcript
- News
Agilent Technologies Q3 Adj. EPS $1.62 Beats $1.49 Estimate, Sales $1.878B Beat $1.841B Estimate
- Press releaseBusiness Wire
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
- Press releaseBusiness Wire
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
- Press releaseBusiness Wire
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
- Press releaseBusiness Wire
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
- Press releaseBusiness Wire
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
- Press releaseBusiness Wire
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
- Press releaseBusiness Wire
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
- Press releaseGlobe Newswire
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
- Press releaseBusiness Wire
Agilent Completes Acquisition of Biocare Medical
- News
Agilent Technologies Q2 2026 Earnings Call: Complete Transcript
- Press releaseBusiness Wire
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
- Press releaseBusiness Wire
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
- News
Stock Market Today: S&P 500, Dow Futures Inch Up As US-Iran Deal Awaits Trump Approval — Dell, Agilent, Hewlett Packard Enterprise In Focus
- NewsAvi Kapoor
Agilent Technologies, Snowflake And 3 Stocks To Watch Heading Into Friday
- NewsPriya Nigam
Agilent Technologies Stock Soars On Broad Q2 Beat, Company Stands Out In Tools Sector
- NewsPiero Cingari
S&P 500 Hits Record Highs, Snowflake Jumps 37% On AI Boom: Stock Market Today
- News
Agilent Launches OpenLab Sync To Help Laboratories Digitally Connect Scientific Workflows From Method Design Through Bench Execution
- Press releaseBusiness Wire
Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory
- Press releaseBusiness Wire
Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
- Press releaseBusiness Wire
Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control
- Press releaseBusiness Wire
Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality
- Press releaseBusiness Wire
Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis
- Press releaseBusiness Wire
Agilent Announces Cash Dividend of 25.5 Cents per Share
- Press releaseBusiness Wire
Agilent Names Michael Buckner as Chief Legal Officer
- NewsCaroline Ryan
Deal Dispatch: Papa John's May Go Private, Shell Buys Jiffy Lube, Meta Acquires Moltbook
- NewsLekha Gupta
Agilent Bets On Pathology Innovation With Biocare Acquisition
- Press releaseBusiness Wire
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results
- Press releaseBusiness Wire
Agilent Announces Cash Dividend of 25.5 Cents per Share
- NewsAvi Kapoor
These Analysts Boost Their Forecasts On Agilent After Upbeat Q4 Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.